医療機器リーダーシリーズ:薬剤充填済み注入器トップメーカー2016-2026

◆英語タイトル:Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2016-2026
◆商品コード:VGAIN81927
◆発行会社(調査会社):visiongain
◆発行日:2016年8月
◆ページ数:231
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Sigle User(1名利用)GBP1,999 ⇒換算¥283,858見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥425,858見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥709,858見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongain社の日本における正規販売代理店です。visiongain社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートは以下の構成でお届けいたします。
1. レポート概要

2. 薬剤充填済み注入器の概要

3. プレフィルドシリンジ製造市場における主要企業

4. 薬剤充填済み注入器部品製造市場における主要企業

5. ペン型注入器・自動注入器製造市場における主要企業

6. 薬剤充填済み注入器受託製造市場における主要企業

7. 調査インタビュー

8. 結論
【レポートの概要】

Pre-Filled Syringes and Related Drug Delivery – Discover Leading Companies’ Revenue Potentials
How are companies in the pre-filled syringe industry performing? Visiongain’s new report gives you data, analysis and discussions for producers of those drug delivery devices.

Our study lets you assess companies in the pre-filled (ready-to-fill) syringe industry and market, showing you their prospects to 2026. There you see financial results, opinion, trends, opportunities and sales predictions.

That way you discover potentials of established and rising companies. Read on, please, to scan those organisations and see what their future market could be worth.

Forecasts and discussions to help you stay ahead in knowledge and authority
Our new study assesses 25 top companies – and analyses that overall industry – with sales results, revenue forecasts and growth rates. In our 230 page report you gain 86 tables, 30 charts and a research interview.

You also get qualitative analyses, including research and development. Our work lets you assess the most beneficial and lucrative applications of those drug delivery technologies. There you see opportunities for producers of medical injection devices and manufacturers of biologics, insulins and vaccines.

That way you stay ahead in knowledge of the industry and market for these medical devices, helping your influence. You explore leading developers, producers and marketers of these products:
• Plastic and glass pre-filled syringes
• Pen injectors and autoinjectors, including insulin delivery
• Related components and safety systems, including needles, shields, Luer fitments, plungers and tip caps
• Contract manufacturing organisations (CMOs) providing filling services for pre-filled injection devices (syringes and cartridges).

The following sections describe how our new investigation helps your work.

Company profiles – discover why firms succeed, also exploring their prospects
Our report profiles 25 leading companies worldwide across four segments of the pre-filled injection devices market. The content of each discussion differs, depending on the company. In general a profile contains the following information:
• Overview of the firm, showing its place in the pre-filled injection devices field
• Discussion of the company’s product or service portfolio, including clients
• Analysis of the player’s recent financial performance, esp. relevant sales
• Coverage of developments – e.g. acquisitions, R&D, expansions, launches and collaborations with the pharmaceutical industry
• Prospects of the company – strengths over competitors and opportunities
• Prediction of revenue for the period 2016-2026 (for 10 companies).

Our survey shows how product and service demand changed in recent years, as well as explaining how those needs can develop from 2016 – rising demand.

Prospects for leading pre-filled syringe manufacturers
Our study gives you discussions and financial analyses for developers and producers of pre-filled injection devices – these five leaders and other firms:
• Becton, Dickinson & Co. (BD)
• Gerresheimer
• Schott
• Nipro
• Ompi.

There you discover what the future holds for those medical device companies, seeing how they compare and compete. You find where the best prospects for business exist.

Suppliers and users of pre-filled injection systems will benefit from 2016. Next, our work analyses developers, producers and providers of associated technology.

Outlooks for manufacturers of pre-filled syringe components
The report shows you developments and revenue prospects for leading producers of syringe components and related accessories, including these companies:
• Aptar Stelmi
• Dätwyler Holding
• West Pharmaceutical Services.

In our study you explore opportunities for companies making injection safety systems, plungers, needle shields, caps and related products.

Our work shows you where sales growth can occur. Many opportunities remain, with expanding revenues likely from 2016 to 2026. See what is possible.

Potentials of leading pen injector and autoinjector producers
In our study you also see commercial outlooks for top manufacturers of pen injectors and autoinjectors, including these companies:
• Haselmeier
• Owen Mumford
• SHL Group
• Ypsomed.

There you assess product portfolios, strategies and revenue prospects. You also investigate associated organisations and competition. Our work shows you possibilities for advancing technologies and raising sales.

Contract manufacturers in that parenteral drug delivery
Our work also assesses contract manufacturing organisations (CMOs) in that field. There you explore these production service providers and others:
• Catalent
• Hospira One2One
• Vetter Pharma.

That way you assess the capabilities and outlooks of healthcare CMOs in that field. You also scan applications for biological drugs (biologics), lyophilisation and dual-chamber syringes, among other advances.

Value of that market in 2020 – what sales growth is possible and why?
Our analysis predicts overall world revenues for those pre-filled injection devices – the drug delivery technology – will reach $6940m in 2020. Those sales will expand further to 2026, showing strong revenue growth. Many opportunities remain.

Greater use of biologics and vaccines raise demand for parenteral delivery systems. Many opportunities exist, especially for plastic syringes, polymers and ready-to-use containment of labile drugs and other complex pharmaceuticals. Our study explains.

What about applications? Rising incidence of diabetes and expansion of the home healthcare market stimulate demand for pre-filled injection products. Explore what is possible, staying ahead. In our study you see what those companies’ futures hold.

5 ways Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2016-2026 helps your work
In particular our new investigation gives you this knowledge to benefit your research, analyses, plans and presentations:
• Profiles of 25 leading companies – assess their products, technologies, activities, partnerships, developments and results
• Forecast revenue to 2026 for that overall market at world level – discover expected sales rises for pre-filled drug delivery devices and services
• Predicted revenues for top companies – see potential sales to 2026 for 10 leading participants
• Competition and opportunities – explore what affects that industry, seeing forces that influence its sales and determine its future
• Opinion from an interview with a leading company – gain insight to help you stay ahead in knowledge, benefiting your reputation for insight.

That study, by our in-house analysts in the UK, has the purpose of helping your work. There you gain data and insight you find nowhere else, to help you succeed.

Independent analysis to benefit your authority on pre-filled drug delivery
Our work gives independent analysis. There you receive business intelligence found only in that report, seeing where technological and financial prospects are most rewarding, as well as companies’ potentials from 2016 to 2026.

With our study you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses and decisions, also saving time and gaining in authority. Explore that industry’s future, seeing what is possible and how you can gain.

Our new investigation is for everyone assessing the industry and market for drug delivery by injection. There you find data, trends, opportunities and forecasts. Avoid missing out. Benefit in knowledge and influence by requesting our report now.

【レポートの目次】

1. Report Overview
1.1 Global Pre-Filled Injection Devices Market Overview
1.2 Pre-Filled Injectable Devices Market Segmentation
1.3 Top Pre-Filled Injectable Devices Market: An Overview
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Pre-Filled Injectable Devices
2.1 What are Pre-Filled Injectable Devices?
2.2 Classification of Companies in the Pre-Filled Injectable Devices Market
2.2.1 Pen Injectors and Autoinjectors
2.2.2 Benefits and Weaknesses of Pre-Filled Injectors
2.3 The Pre-Filled Injection Devices Market 2016-2026
2.4 Contract Manufacturing as a Sector of the Pre-Filled Injectable Devices Market
2.5 Demand on the Western Market is the Highest
2.6 Key Trends in the Pre-Filled Injection Device Market 2016-2026
2.6.1 Increased Market Consolidation
2.6.2 Increased Development of Biologics and Biosimilars
2.6.3 Rise In At Home Care
2.6.4 Greater Demands for Safety Leading Innovation
2.6.5 Threat from Other Drug Delivery Technologies

3. Leading Companies in the Pre-Filled Syringes Manufacturing Market 2016-2026
3.1 Becton, Dickinson, & Co (BD)
3.1.1 BD: Broad Portfolio of Syringe Products
3.1.1.1 BD Hypak: The First Glass Pre-Filled Syringe Worldwide
3.1.1.2 BD Sterifill
3.1.1.3 BD Soluvia
3.1.1.4 BD Uniject on the Emerging Market
3.1.1.5 BD Physioject Autoinjector
3.1.1.6 BD Nano 4mm Pen Needles
3.1.1.7 BD Pen Injectors: BD Liquid Dry Injector and BD Reusable Pen
3.1.1.8 BD Vystra Disposable Pen
3.1.1.9 BD Neopak
3.1.1.10 BD Proprietary Syringe Safety Systems
3.1.1.11 The BD Emerald Portfolio
3.1.2 New Product Launches Planned
3.1.3 BD Acquires Safety Syringes
3.1.4 BD’s Pre-Filled Injection Historical Revenue 2014-2015
3.1.5 Major Acquisitions and Focus on Core Competencies
3.1.6 BD’s Main Strategic Goals
3.1.7 BD: Trend for Strategic Partnering
3.1.8 BD SWOT Analysis, 2016-2026
3.1.8.1 Collaboration and Expansion: Strategies for Growth and Rebranding
3.1.8.2 BD Medical Revenue Forecast 2015-2026
3.2 Gerresheimer
3.2.1 Pre-Filled Syringe Manufacture at Gerresheimer
3.2.1.1 RTF (Ready-To-Fill) Glass Syringes at Gerresheimer
3.2.1.2 ClearJect RTF Plastic Syringes at Gerresheimer
3.2.1.3 New German-made RTF ClearJect Syringe Combines the RTF Concept with Plastic
3.2.2 Pen Injector Manufacture at Gerresheimer
3.2.3 Gerresheimer Historical Revenue 2014-2015
3.2.4 Strategic Sale of Glass Tubing Business: Company Focus on Medical Devices and Primary Packaging
3.2.5 Strong Growth in the Plastics and Devices Division with a Focus on Modernisation
3.2.6 Standardisation as a Strategy
3.2.7 Gerresheimer SWOT Analysis, 2016-2026
3.2.7.1 Rapid Growth Planned for Emerging Markets
3.2.7.2 Gerresheimer is Well-Placed for Biologics Growth and More Stringent Regulatory Changes
3.2.7.3 Gerresheimer Pen Injector Market Revenue Forecast 2015 to 2026
3.3 Schott
3.3.1 Schott Markets Glass and Plastic Pre-Filled Syringes
3.3.1.1 Glass Syringes at Schott: Forma 3s and syriQ
3.3.1.2 TopPac Polymer Syringes
3.3.1.3 InJentle Syringes for Sensitive Drug Products
3.3.1.4 Other New Innovations at Schott
3.3.2 Schott Historical Revenue
3.3.3 Expansion in Developed and Emerging Markets
3.3.3.1 Growth in the Emerging Market
3.3.4 Schott SWOT Analysis, 2016-2026
3.3.4.1 Schott’s Emerging Market Strategy
3.4 Nipro Medical Corporation
3.4.1 Overview of Nipro’s Pre-Filled Syringe Portfolio
3.4.2 New Products at Nipro
3.4.3 Nipro is Expanding Globally
3.4.4 Nipro SWOT Analysis, 2016-2026
3.4.4.1 Responding to Rising Diabetes Incidence
3.5 Stevanato Group/Ompi
3.5.1 Ompi Markets Glass Pre-Filled Syringes and Cartridges
3.5.1.1 EZ-Fill Syringe
3.5.1.2 Extra High Quality (XQ) Syringes
3.5.1.3 Acquisitions and Innovations at Ompi
3.5.2 Focused on Growth for Cartridges and Vials Manufacturing Especially in Emerging Markets
3.5.3 Ompi SWOT Analysis, 2016-2026
3.5.3.1 Ompi’s Products for the Biologics Market
3.5.3.2 Investing to Expand Capacity and Deal with Increasing Demand
3.6 Pre-Filled Syringe Manufacturers: Competitor Analysis 2016 to 2026
3.6.1 The Need for Advanced Safety Systems
3.6.2 Meeting the Demands of Biologics and Biosimilar Developers
3.6.3 Product Portfolio Diversity
3.6.4 What Demand is there in Emerging Markets?
3.7 High Barriers to Market Entry Will Limit Competition to 2026
3.8 Other Manufacturers of Interest in this Market
3.8.1 Unilife
3.8.1.1 Unilife’s Many Collaborations
3.8.1.2 Unilife’s Historical Revenue 2013-2015
3.8.2 Revolutions Medical: A Disposable Syringe Manufacturer Entering the Pre-Filled Market
3.8.3 Weigao Group Pharmaceutical Packaging Products Company
3.8.3.1 Weigao’s Historical Revenue 2013-2015
3.8.3.2 Weigao Pre-Filled Syringes Revenue Forecast 2015-2026
3.8.4 Roselabs Group

4. Leading Companies in the Pre-Filled Injectable Components Manufacturing Market
4.1 Aptar Stelmi is a Pharma Packaging Specialist
4.1.1 Aptar Stelmi’s Pre-Filled Syringe Components
4.1.1.1 Aptar Stelmi’s Rigid Needle Shields
4.1.2 Aptar: Strategically Increasing Market Access to the Autoinjector Market
4.1.3 Aptar Stelmi’s Expansion and Innovations
4.1.4 Aptar Stelmi’s Historical Revenue 2013-2015
4.1.5 Aptar Stelmi SWOT Analysis, 2016-2026
4.1.5.1 Regional Expansion is Important for Continued Growth
4.1.6 Aptar Stelmi Revenue Forecast 2015-2026
4.2 Dätwyler Holding
4.2.1 Dätwyler’s Pre-Filled Syringe Components
4.2.1.1 Omniflex Coating: An Alternative to Silicone Oil
4.2.2 Demand from Insulin Manufacturers Drives Revenue Growth 2013-2015
4.2.3 Dätwyler is Focused on Strategic Acquisition and Expansion
4.2.4 Growth in Emerging Markets
4.2.5 Dätwyler SWOT Analysis, 2016-2026
4.2.6 Dätwyler Healthcare Revenue Forecast 2015-2026
4.3 West Pharmaceutical Services
4.3.1 West Manufactures Syringes and Syringe Components
4.3.1.1 Daikyo Crystal Zenith: Licensed from Daikyo Seiko
4.3.1.2 MixJect for Lyophilised Drugs
4.3.1.3 West’s Self-Injection Systems
4.3.1.4 West Markets Three Safety Systems
4.3.1.5 Innovation and Investment at West
4.3.2 Recent Financial Performance
4.3.3 Collaborations with Big Pharma for Product Development
4.3.4 Expansion at West
4.3.5 West SWOT Analysis, 2016-2026
4.3.6 West Pharmaceutical Revenue Forecast 2015-2026
4.4 Pre-Filled Syringe Component Manufacturers: Competitor Analysis 2016-2026
4.4.1 How Can Component Manufacturers React to Increased Safety Demands?
4.4.2 Other Manufacturers of Interest in this Market
4.4.2.1 Tip-top: Three Safety Products for Pre-Filled Syringes
4.4.2.2 Nemera: Formed from Rexam’s Sale of Healthcare Division
4.4.3 Entering the Autoinjector Market
4.4.4 Component Manufacturers Following Pre-Filled Syringe Manufacturers to Emerging Markets

5. Leading Companies in the Pen Injector and Autoinjector Manufacturing Market 2016-2026
5.1 Haselmeier
5.1.1 Haselmeier Markets Five Injection Systems
5.1.1.1 Axis Pen Systems
5.1.1.2 i-Pen: Haselmeier’s Insulin Pen Injector
5.1.2 Company Growth in Germany and India
5.1.3 Haselmeier SWOT Analysis, 2016-2026
5.2 Owen Mumford
5.2.1 Autoinjector and Pen Injector Overview
5.2.1.1 Autoject
5.2.1.2 Autopen
5.2.1.3 SimpleJect: Designed for RA Patients
5.2.2 Innovative Products to Drive Growth
5.2.3 Expanding in Established and New Markets
5.2.4 Owen Mumford SWOT Analysis 2016-2026
5.3 SHL Group
5.3.1 SHL Manufactures a Broad Range of Injection Devices
5.3.1.1 DAI Autoinjectors
5.3.2 SHL Group Continues to Grow in Taiwan
5.3.3 SHL Group SWOT Analysis, 2016-2026
5.4 Ypsomed
5.4.1 Product Portfolio
5.4.1.1 YpsoPen
5.4.1.2 ServoPen
5.4.1.3 UnoPen
5.4.1.4 LyoTwist Injectors for Lyophilised Drugs
5.4.1.5 Ypsomed Markets Two Autoinjectors
5.4.1.6 Expansion at Ypsomed: Current and Future Plans
5.4.2 Ypsomed: Financial Performance 2013-2015
5.4.3 A Focus on Diabetes
5.4.4 Ypsomed SWOT Analysis, 2016-2026
5.4.5 Ypsomed Delivery Devices Revenue Forecast 2015-2026
5.5 Pen Injector and Autoinjector Manufacturers: Competitor Analysis 2015-2026
5.5.1 A Competitive Market 2016-2026
5.5.2 Other Manufacturers of Interest in this Market
5.5.2.1 Bespak Injectables
5.5.3 How Are Companies Differentiating Their Autoinjectors?
5.5.4 Rising Demand in At-Home Care
5.5.4.1 Specific Demands in RA and MS
5.5.5 Contract Manufacturing for Autoinjectors

6. Leading Companies in the Contract Pre-Filled Injectable Devices Manufacturing Market 2016-2026
6.1 Catalent is the World’s Largest CMO
6.1.1 Pre-Filled Syringe Contract Manufacturing Capabilities
6.1.2 Catalent Offers an Autoinjector
6.1.3 Innovations at Catalent
6.1.4 Catalent Pharma Solutions: Financial Performance 2013-2015
6.1.5 Expanding Filling Capacity for Clinical Trial Materials
6.1.6 Possible Acquisition of Catalent by Lonza
6.1.7 Catalent SWOT Analysis 2016-2026
6.1.8 Catalent Pre-Filled Syringe and Cartridge Filling Revenue Forecast 2015-2026
6.2 Hospira One2One
6.2.1 Hospira and the Pre-Filled Injection Device Industry
6.2.1.1 iSecure Syringe: Hospira’s Pre-Filled Injection System
6.2.2 Hospira: Uncertain Future
6.2.3 Hospira SWOT Analysis, 2016-2026
6.2.4 Hospira One2One: Pre-Filled Injection Device Revenue Forecast 2015-2026
6.3 Vetter Pharmaceutical
6.3.1 Vetter is an Injectable Manufacturing Specialist
6.3.2 Vetter’s Ten Year Expansion Plan
6.3.3 New Services and Collaborations
6.3.4 Vetter SWOT Analysis 2016 to 2026
6.3.5 Outlook for Vetter: Pre-Filled Injection Device Revenue Forecast 2015-2026
6.4 The Competitive Outlook for Leading CMOs in the Market 2016-2026
6.4.1 Biologics, Lyophilisation, and Dual-Chamber Syringes
6.4.2 An Increasingly Competitive Market
6.4.3 Important of Keeping Up with Regulations
6.5 Other Pre-Filled Syringe Contract Manufacturers 2016
6.5.1 Laboratorios Farmacéuticos ROVI
6.5.1.1 ROVI CM’s Pre-Filled Syringe Capabilities
6.5.2 Albany Molecular Research Inc (AMRI): Strategic Acquisitions
6.5.2.1 AMRI’s Recent Financial Performance
6.5.3 Boehringer Ingelheim

7. Research Interviews
7.1 Interview with Gerresheimer
7.1.1 Drivers and Restraints in the Pre-Filled Devices Market
7.1.2 Pre-Filled Medical Device Development at Gerresheimer
7.1.3 Future Trends in the Pre-Filled Medical Devices Market

8. Conclusions
8.1 Outlook for the Pre-Filled Injection System Market 2016-2026
8.2 Outlook for Leading Pre-Filled Injection System Manufacturers 2016-2026
8.2.1 How Will Leading Companies’ Revenues Grow to 2026?
8.3 The Future of the Pre-Filled Medical Devices Market

List of Tables
Table 1.1 Currency Exchange Rates
Table 2.1 Total Pre-Filled Device Manufacturing Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 2.2 Pre-Filled Injection Device Market by Region, 2015
Table 2.3 Pre-Filled Injection Device Market: STEP Analysis, 2016-2026
Table 2.4 Selected Recent Acquisitions in the Pre-Filled Injection Devices Industry
Table 3.1 BD Overview, 2016
Table 3.2 BD Historical Revenue by Division ($m), 2014
Table 3.3 BD Revenue by Division ($m), AGR (%), 2014-2015
Table 3.4 Medical Division Revenue ($m), 2014-2015
Table 3.5 BD: Pharmaceutical Systems Revenue ($m), AGR (%), CAGR (%), 2013-2015
Table 3.6 BD Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 3.7 BD Pharmaceutical Systems Revenue Forecast ($m), AGR (%), CAGR (%), 2015-2026
Table 3.8 Gerresheimer Employees by Region, 2015
Table 3.9 Gerresheimer Overview, 2016
Table 3.10 Gerresheimer Revenue by Division ($m), AGR ($), CAGR ($), 2014-2015
Table 3.11 Gerresheimer Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 3.12 Gerresheimer Pen Injectors: Revenue Forecast ($m), AGR (%), CAGR (%), 2015-2026
Table 3.13 Schott Overview, 2016
Table 3.14 Schott Revenue ($m), AGR (%), CAGR (%), 2013-2015
Table 3.15 Schott Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 3.16 Nipro Overview, 2016
Table 3.17 Nipro Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 3.18 Stevanato Group/Ompi Overview, 2016
Table 3.19 Ompi Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 3.20 Pre-Filled Syringes: Leading Product Comparisons, 2016
Table 3.21 Leading Pre-Filled Syringe Manufacturers: Comparative Product Ranges, 2016
Table 3.22 Unilife Overview, 2016
Table 3.23 Unilife: Revenue, ($m), AGR (%), CAGR (%), 2013-2015
Table 3.24 Revolutions Medical: RevVac Distribution Agreements, 2011-2014
Table 3.25 Weigao Group Pharmaceutical Packaging Products Company Overview, 2016
Table 3.26 Weigao: Pre-Filled Syringes Revenue ($m), AGR (%), CAGR (%), 2013-2015
Table 3.27 Weigao: Revenue Forecast ($m), AGR (%), CAGR (%), 2015-2026
Table 3.28 Roselabs Group Overview, 2016
Table 4.1 Aptar Stelmi Overview, 2016
Table 4.2 Aptar Stelmi: Revenue ($m), AGR (%), CAGR (%), 2013-2015
Table 4.3 Aptar Stelmi Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 4.4 Aptar Stelmi: Revenue Forecast ($m), AGR (%), CAGR (%), 2015-2026
Table 4.5 Dätwyler Overview, 2016
Table 4.6 Dätwyler: Sealing Solutions Revenue ($m), AGR (%), CAGR (%), 2013-2015
Table 4.7 Dätwyler Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 4.8 Dätwyler Healthcare: Revenue Forecast ($m), AGR (%), CAGR (%), 2015-2026
Table 4.9 West Pharmaceutical Services Overview, 2016
Table 4.10 West: Selected Pharmaceutical Industry Partners, 2016
Table 4.11 West: Revenue by Division ($m), 2013-2015
Table 4.12 West Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 4.13 West: Pre-Filled Syringe and Device Revenue ($m), AGR (%), CAGR (%), 2013-2015
Table 4.14 West Pharmaceuticals: Revenue Forecast ($m), AGR (%), CAGR (%), 2015-2026
Table 4.15 Tip-top Overview, 2016
Table 4.16 Nemera Overview, 2016
Table 5.1 Haselmeier Overview, 2016
Table 5.2 Selected Partners for the i-Pen, 2016
Table 5.3 Haselmeier Pre-Filled Injection Devices: SWOT Analysis, 2016-2016
Table 5.4 Owen Mumford Overview, 2016
Table 5.5 Selected Autoject Range Products, 2016
Table 5.6 Owen Mumford Pre-Filled Injection Devices: SWOT Analysis, 2016 to 2026
Table 5.7 SHL Group Overview, 2016
Table 5.8 SHL Group: Pen Injectors and Autoinjectors, 2016
Table 5.9 SHL Group Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 5.10 Ypsomed Overview, 2016
Table 5.11 Ypsomed: Pen Injectors and Autoinjectors, 2016
Table 5.12 Selected Pharmaceutical Partners for Ypsomed’s Pen Injectors, 2013
Table 5.13 LyoTwist Injectors Available, 2016
Table 5.14 Ypsomed: Revenue by Division ($m), CAGR (%), 2013-2015
Table 5.15 Ypsomed Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 5.16 Ypsomed Delivery Devices: Revenue Forecast ($m), AGR (%), CAGR (%), 2015-2026
Table 5.17 Pen Injectors: Selected Product Comparisons, 2016
Table 5.18 Autoinjectors: Selected Product Comparisons, 2016
Table 5.19 Selected Other Pen Injector and Autoinjector Manufacturers, 2016
Table 5.20 Bespak Injectables Overview, 2016
Table 6.1 Catalent Overview, 2016
Table 6.2 Catalent: Employees by Region, 2016
Table 6.3 Catalent: Revenue by Division ($m), CAGR (%), 2013-2015
Table 6.4 Catalent Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 6.5 Catalent Medication Delivery Solutions Division: Revenue Forecast ($m), AGR (%), CAGR (%), 2015-2026
Table 6.6 Hospira Overview, 2016
Table 6.7 Hospira Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 6.8 Hospira One2One Pre-Filled Injection Device Filling: Revenue Forecast ($m), 2015-2026
Table 6.9 Vetter Pharma Overview, 2016
Table 6.10 Vetter Pre-Filled Injection Devices: SWOT Analysis, 2016-2026
Table 6.11 Vetter Pre-Filled Injection Device Filling: Revenue Forecast ($m), 2015-2026
Table 6.12 Leading Pre-Filled Syringe CMOs: Company Comparison, 2016
Table 6.13 Laboratorios Farmacéuticos ROVI Overview, 2016
Table 6.14 Laboratorios Farmacéuticos ROVI: Revenue ($m), AGR (%), CAGR (%), 2013-2015
Table 6.15 AMRI Overview, 2016
Table 6.16 AMRI: Revenue by Division ($m), AGR (%), CAGR (%), 2013-2015
Table 6.17 Boehringer Ingelheim Overview, 2016
Table 8.1 Leading Pre-Filled Injection Device Manufacturers: Revenue Growth, 2015-2026

List of Figures
Figure 1.1 Global Pre-Filled Injectable Devices Market Segmentation Overview, 2016
Figure 2.1 Total Pre-Filled Device Manufacturing Market Forecast: Revenues ($m), 2015-2026
Figure 2.2 Pre-Filled Injection Device Market by Region, 2015
Figure 3.1 BD Historical Revenue by Division ($m), 2014
Figure 3.2 BD Revenue by Division ($m), 2014-2015
Figure 3.3 BD: Pharmaceutical Systems Revenue ($m), 2013-2015
Figure 3.4 BD Pharmaceutical Systems Revenue Forecast ($m), 2015-2026
Figure 3.5 Gerresheimer: Employees by Region, 2015
Figure 3.6 Gerresheimer: Revenue by Division ($m), 2014-2015
Figure 3.7 Gerresheimer Pen Injectors: Revenue Forecast ($m), 2015-2026
Figure 3.8 Schott Revenue ($m), 2013-2015
Figure 3.9 Unilife: Revenue ($m), 2013-2015
Figure 3.10 Weigao: Pre-Filled Syringes Revenue ($m), 2013-2015
Figure 3.11 Weigao: Revenue Forecast ($m), 2015-2026
Figure 4.1 Aptar Stelmi: Revenue ($m), 2013-2015
Figure 4.2 Aptar Stelmi: Revenue Forecast ($m), 2015-2026
Figure 4.3 Dätwyler: Sealing Solutions Revenue ($m), 2013-2015
Figure 4.4 Dätwyler Healthcare: Revenue Forecast ($m), 2015-2026
Figure 4.5 West: Revenue by Division ($m), 2013-2015
Figure 4.6 West: Pre-Filled Syringe and Device Revenue ($m), 2013-2015
Figure 4.7 West Pharmaceuticals: Revenue Forecast ($m), 2015-2026
Figure 5.1 Ypsomed: Revenue by Division ($m), 2013-2015
Figure 5.2 Ypsomed Delivery Devices: Revenue Forecast ($m), 2015-2026
Figure 6.1 Catalent: Employees by Region, 2016
Figure 6.2 Catalent: Revenue by Division ($m), 2013-2015
Figure 6.3 Catalent Medication Delivery Solutions Division: Revenue Forecast ($m), 2015-2026
Figure 6.4 Hospira One2One Pre-Filled Injection Device Filling: Revenue Forecast ($m), 2015-2026
Figure 6.5 Vetter Pre-Filled Injection Device Filling: Revenue Forecast ($m), 2015-2026
Figure 6.6 Laboratorios Farmacéuticos ROVI: Revenue ($m), 2013-2015
Figure 6.7 AMRI: Revenue by Division ($m), 2013-2015

★調査レポート[医療機器リーダーシリーズ:薬剤充填済み注入器トップメーカー2016-2026]販売に関する免責事項
★調査レポート[医療機器リーダーシリーズ:薬剤充填済み注入器トップメーカー2016-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆